Anticholinergics: theoretical and clinical overview

Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627 · see citing works

Acetylcholinesterase Inhibitors: Pharmacology and Toxicology

Colovic, M. B., Krstic, D. Z., Lazarevic-Pasti, T. D., Bondzic, A. M., & Vasic, V. M. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311030006 · Cited by 2,611 · see citing works

American Geriatrics Society 2015 Updated Beers Criteria for potentially inappropriate medication use in older adults

By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609 · see citing works

Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications

Mangoni, A. A., & Jackson, S. H. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.02007.x · Cited by 1,887 · see citing works

Occurrence and outcome of delirium in medical in-patients: a systematic literature review

Siddiqi, N., House, A. O., & Holmes, J. D. (2006) · Age and Ageing · doi:10.1093/ageing/afl005 · Cited by 1,185 · see citing works

Goodman and Gilman's The Pharmacological Basis of Therapeutics.

(1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-3-453_1 · Cited by 1,015 · see citing works

Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis

Farrall, A. J., & Wardlaw, J. M. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.015 · Cited by 882 · see citing works

Impact of Anticholinergics on the Aging Brain: A Review and Practical Application

Boustani, M. A., Campbell, N. L., Munger, S., Maidment, I. D., & Fox, C. (2008) · Aging Health · doi:10.2217/1745509x.4.3.311 · Cited by 836 · see citing works

The anticholinergic risk scale and anticholinergic adverse effects in older persons

Rudolph, J. L. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.106 · Cited by 835 · see citing works

A Drug Burden Index to Define the Functional Burden of Medications in Older People

Hilmer, S. N. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.8.781 · Cited by 761 · see citing works

The Anticholinergic Drug Scale as a Measure of Drug‐Related Anticholinergic Burden: Associations With Serum Anticholinergic Activity

Carnahan, R. M., Lund, B. C., Perry, P. J., Pollock, B. G., & Culp, K. R. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006292126 · Cited by 666 · see citing works

Anticholinergic Medication Use and Cognitive Impairment in the Older Population: The Medical Research Council Cognitive Function and Ageing Study

Fox, C., Richardson, K., Maidment, I. D., Savva, G. M., Matthews, F. E., Smithard, D. G., Coulton, S., Katona, C., Boustani, M. A., & Brayne, C. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03491.x · Cited by 640 · see citing works

Blood brain barrier: ageing and microvascular disease-systematic review and meta-analysis

Farrall, A., & Wardlaw, J. M. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.089 · Cited by 639 · see citing works

Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder

Abrams, P., Andersson, K., Buccafusco, J. J., Chapple, C. R., de Groat, W. C., Fryer, A. D., Kay, G. G., Laties, A. M., Nathanson, N. M., Pasricha, P. J., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706780 · Cited by 630 · see citing works

Estimation of Blood-Brain Barrier Crossing of Drugs Using Molecular Size and Shape, and H-Bonding Descriptors

Waterbeemd, H. V. D., Camenisch, G., Folkers, G., Chrétien, J. R., & Raevsky, O. A. (1998) · Journal of drug targeting · doi:10.3109/10611869808997889 · Cited by 587 · see citing works

Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study

Ancelin, M., Artéro, S., Portet, F., Dupuy, A., Touchon, J., & Ritchie, K. A. (2006) · BMJ · doi:10.1136/bmj.38740.439664.de · Cited by 575 · see citing works

The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial

Ballard, C., Hanney, M. L., Theodoulou, M., Douglas, S., McShane, R., Kossakowski, K., Gill, R., Juszczak, E., Yu, L.-M., & Jacoby, R. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70295-3 · Cited by 567 · see citing works

Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review

Salahudeen, M. S., Duffull, S. B., & Nishtala, P. S. (2015) · BMC Geriatrics · doi:10.1186/s12877-015-0029-9 · Cited by 553 · see citing works

Anticholinergic Activity of 107 Medications Commonly Used by Older Adults

Chew, M. L., Mulsant, B. H., Pollock, B. G., Lehman, M. E., Greenspan, A. J., Mahmoud, R. A., Kirshner, M. A., Sorisio, D. A., Bies, R. R., & Gharabawi, G. M. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01737.x · Cited by 499 · see citing works

Risk factors for incident delirium among older people in acute hospital medical units: a systematic review and meta-analysis

Ahmed, S., Leurent, B., & Sampson, E. L. (2014) · Age and Ageing · doi:10.1093/ageing/afu022 · Cited by 463 · see citing works

Age and cytochrome P450-linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions*

Sotaniemi, E. A., Arranto, A. J., Pelkonen, O., & Pasanen, M. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90166-1 · Cited by 416 · see citing works

Antimuscarinics for treatment of overactive bladder

Andersson, K. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00622-7 · Cited by 416 · see citing works

Muscarinic acetylcholine receptors as CNS drug targets

Langmead, C. J., Watson, J. M., & Reavill, C. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.009 · Cited by 413 · see citing works

Anticholinergic effects of medication in elderly patients.

Tune, L. E. (2001) · PubMed · Cited by 402 · see citing works

Management of drug therapy in the elderly

Desforges, J. F., Montamat, S. C., Cusack, B. J., & Vestal, R. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210507 · Cited by 388 · see citing works

Cholinesterase Inhibitors: A New Class of Psychotropic Compounds

Cummings, J. L. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.4 · Cited by 383 · see citing works

Drugs With Anticholinergic Properties, Cognitive Decline, and Dementia in an Elderly General Population

Carrière, I., Fourrier‐Réglat, A., Dartigues, J., Rouaud, O., Pasquier, F., Ritchie, K. A., & Ancelin, M. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.229 · Cited by 367 · see citing works

Drugs with anticholinergic effects and cognitive impairment, falls and all‐cause mortality in older adults: A systematic review and meta‐analysis

Ruxton, K., Woodman, R. J., & Mangoni, A. A. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12617 · Cited by 365 · see citing works

Age-Related Changes in Pharmacokinetics

Shi, S., & Klotz, U. E. (2011) · Current Drug Metabolism · doi:10.2174/138920011796504527 · Cited by 351 · see citing works

Xerostomia: Clinical Aspects and Treatment

Cassolato, S. F., & Turnbull, R. S. (2003) · Gerodontology · doi:10.1111/j.1741-2358.2003.00064.x · Cited by 349 · see citing works

Systematic review of anticholinergic risk scales in older adults

Durán, C. E., Azermai, M., & Stichele, R. V. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1499-3 · Cited by 346 · see citing works

Medication-Related Falls in the Elderly

Huang, A. R., Mallet, L., Rochefort, C. M., Eguale, T., Buckeridge, D. L., & Tamblyn, R. M. (2012) · Drugs & Aging · doi:10.2165/11599460-000000000-00000 · Cited by 345 · see citing works

Anticholinergic side-effects of drugs in elderly people

Mintzer, J. E., & Burns, A. S. (2000) · Journal of the Royal Society of Medicine · doi:10.1177/014107680009300903 · Cited by 323 · see citing works

Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium

Tune, L. E., Carr, S., Hoag, E. W., & Cooper, T. B. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.10.1393 · Cited by 317 · see citing works

The Aging Liver

Couteur, D. G. L., & McLean, A. J. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199834050-00003 · Cited by 308 · see citing works

Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus

Volpicelli‐Daley, L. A., & Levey, A. I. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45003-6 · Cited by 299 · see citing works

The Problems of Anticholinergic Adverse Effects in Older Patients

Feinberg, M. (1993) · Drugs & Aging · doi:10.2165/00002512-199303040-00004 · Cited by 299 · see citing works

Clinical pharmacology in the geriatric patient

Hilmer, S. N., McLachlan, A. J., & Couteur, D. G. L. (2007) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00473.x · Cited by 298 · see citing works

Serum Anticholinergic Activity in a Community-Based Sample of Older Adults

Mulsant, B. H., Pollock, B. G., Kirshner, M. A., Shen, C., Dodge, H. H., & Ganguli, M. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.2.198 · Cited by 279 · see citing works

Pharmacodynamics in Older Adults: A Review

Bowie, M. W., & Slattum, P. W. (2007) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2007.10.001 · Cited by 268 · see citing works

Drug Burden Index Score and Functional Decline in Older People

Hilmer, S. N., Mager, D. E., Simonsick, E. M., Ling, S. M., Windham, B. G., Harris, T. B., Shorr, R. I., Bauer, D. C., & Abernethy, D. R. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.02.021 · Cited by 255 · see citing works

Neuropsychiatric aspects of Alzheimer's disease

Cummings, J. L., & Kaufer, D. (1996) · Neurology · doi:10.1212/wnl.47.4.876 · Cited by 252 · see citing works

Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study

Ehrt, U., Broich, K., Larsen, J. O., Ballard, C. G., & Aarsland, D. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.186239 · Cited by 247 · see citing works

ASSOCIATION OF POSTOPERATIVE DELIRIUM WITH RAISED SERUM LEVELS OF ANTICHOLINERGIC DRUGS

Tune, L. E., Holland, A., Folstein, M., Damlouji, N. F., Gardner, T., & Coyle, J. T. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90994-6 · Cited by 246 · see citing works

Regulation of muscarinic acetylcholine receptor signaling

van Koppen, C. J., & Kaiser, B. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00032-9 · Cited by 239 · see citing works

Cumulative Anticholinergic Exposure Is Associated with Poor Memory and Executive Function in Older Men

Han, L., Agostini, J. V., & Allore, H. G. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.02009.x · Cited by 238 · see citing works

Blood-brain barrier alterations in ageing and dementia

Popescu, B. O., Toescu, E. C., Popescu, L. M., Bajenaru, O. A., Muresanu, D. F., Schultzberg, M., & Bogdanović, N. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.321 · Cited by 235 · see citing works

Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs

Perry, E. K., Kilford, L., Lees, A. J., Burn, D. J., & Perry, R. H. (2003) · Annals of Neurology · doi:10.1002/ana.10639 · Cited by 229 · see citing works

Antimuscarinic Drugs for Overactive Bladder and Their Potential Effects on Cognitive Function in Older Patients

Kay, G. G., Abou-Donia, M. B., Messer, W. S., Murphy, D., Tsao, J. W., & Ouslander, J. G. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.00537.x · Cited by 226 · see citing works

The Cognitive Cost of Anticholinergic Burden: Decreased Response to Cognitive Training in Schizophrenia

Vinogradov, S., Fisher, M., Warm, H., Holland, C. M., Kirshner, M. A., & Pollock, B. G. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09010017 · Cited by 220 · see citing works

Associations Between Drug Burden Index and Falls in Older People in Residential Aged Care

Wilson, N. M., Hilmer, S. N., MARCH, L. M., Cameron, I. D., Lord, S. R., Seibel, M. J., Mason, R. S., Chen, J., Cumming, R. G., & Sambrook, P. N. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03386.x · Cited by 212 · see citing works

Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study

Lechevallier‐Michel, N., Molimard, M., Dartigues, J., Fabrigoule, C., & Fourrier‐Réglat, A. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02232.x · Cited by 207 · see citing works

Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia

Declercq, T., Petrovic, M., Azermai, M., Vander Stichele, R., De Sutter, A. I., van Driel, M. L., & Christiaens, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007726.pub2 · Cited by 206 · see citing works

The Epidemiology of Serious Adverse Drug Reactions Among the Elderly

Atkin, P. A., Veitch, P. C., Veitch, E. M., & OGLE, S. J. (1999) · Drugs & Aging · doi:10.2165/00002512-199914020-00005 · Cited by 203 · see citing works

Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence

Collamati, A., Martone, A. M., Poscia, A., Brandi, V., Celi, M., Marzetti, E., Cherubini, A., & Landi, F. (2015) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0359-7 · Cited by 202 · see citing works

Drugs with anticholinergic properties: a current perspective on use and safety

Gerretsen, P., & Pollock, B. G. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.579899 · Cited by 196 · see citing works

Blood–brain barrier permeability in Alzheimer's disease: a case–control MRI study

Starr, J. M., Farrall, A., Armitage, P. A., McGurn, B., & Wardlaw, J. M. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2008.04.003 · Cited by 192 · see citing works

Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women

Cao, Y.-J., Mager, D., Simonsick, E., Hilmer, S., Ling, S., Windham, B., Crentsil, V, Yasar, S., Fried, L., & Abernethy, D. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100303 · Cited by 188 · see citing works

Association of Anticholinergic Burden with Cognitive and Functional Status in a Cohort of Hospitalized Elderly: Comparison of the Anticholinergic Cognitive Burden Scale and Anticholinergic Risk Scale

Pasina, L., Djade, C. D., Lucca, U., Nobili, A., Tettamanti, M., Franchi, C., Salerno, F., Corrao, S., Marengoni, A., Iorio, A., et al. (2012) · Drugs & Aging · doi:10.1007/s40266-012-0044-x · Cited by 187 · see citing works

Acetylcholine and Delirium

Tune, L. E., & Egeli, S. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017167 · Cited by 185 · see citing works

Anticholinergic Drugs and Physical Function Among Frail Elderly Population

Landi, F., Russo, A., Liperoti, R., et al. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100035 · Cited by 182 · see citing works

Serum Levels of Anticholinergic Drugs in Treatment of Acute Extrapyramidal Side Effects

Tune, L. E. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780160063007 · Cited by 181 · see citing works

Comparison of Anticholinergic Risk Scales and Associations with Adverse Health Outcomes in Older People

Salahudeen, M. S., Hilmer, S. N., & Nishtala, P. S. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13206 · Cited by 179 · see citing works

Drug Metabolism in Older People--A Key Consideration in Achieving Optimal Outcomes With Medicines

McLachlan, A. J., & Pont, L. G. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glr118 · Cited by 172 · see citing works

Drug Burden Index and physical function in older Australian men

Gnjidic, D., Cumming, R. G., Couteur, D. G. L., Handelsman, D. J., Naganathan, V., Abernethy, D. R., & Hilmer, S. N. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03411.x · Cited by 166 · see citing works

The Risk of Anticholinergic Toxicity in the Elderly: a Study of Prescribing Practices in Two Populations

Blazer, D. G., Federspiel, C. F., Ray, W. A., & Schaffner, W. (1983) · Journal of Gerontology · doi:10.1093/geronj/38.1.31 · Cited by 158 · see citing works

Managing anticholinergic side effects.

Lieberman, J. A. (2004) · PubMed · Cited by 153 · see citing works

Drug Burden Index in older adults: theoretical and practical issues

O’Donnell, L. K., Gnjidic, D., Chen, T. F., Hilmer, S. N., & Mangoni, A. A. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s66660 · Cited by 147 · see citing works

Effects of Anticholinergic Drugs on Cognitive Function in Older Australians: Results from the AIBL Study

Sittironnarit, G., Ames, D. J., Bush, A. I., Faux, N. G., Flicker, L. A., Foster, J. K., Hilmer, S. N., Lautenschlager, N. T., Maruff, P. T., Masters, C. L., et al. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000325171 · Cited by 144 · see citing works

Use of Anticholinergic Medications by Older Adults with Dementia

Roe, C. M., Anderson, M. J., & Spivack, B. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50208.x · Cited by 142 · see citing works

Free Drug Metabolic Clearance in Elderly People

Butler, J. M., & Begg, E. J. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847050-00002 · Cited by 134 · see citing works

Anticholinergic Burden and the Risk of Falls Among Elderly Psychiatric Inpatients: A 4-Year Case-Control Study

Aizenberg, D., Sigler, M., Weizman, A., et al. (2002) · International Psychogeriatrics · doi:10.1017/s1041610202008505 · Cited by 130 · see citing works

Impact and recognition of cognitive impairment among hospitalized elders

Boustani, M. A., Baker, M. S., Campbell, N. L., Munger, S., Hui, S. L., Castelluccio, P., Farber, M. O., Guzman, O., Ademuyiwa, A., Miller, D., et al. (2010) · Journal of Hospital Medicine · doi:10.1002/jhm.589 · Cited by 130 · see citing works

Alternative Medications for Medications in the Use of High‐Risk Medications in the Elderly and Potentially Harmful Drug–Disease Interactions in the Elderly Quality Measures

Hanlon, J. T., Semla, T. P., & Schmader, K. E. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13807 · Cited by 128 · see citing works

Associations of drug burden index with falls, general practitioner visits, and mortality in older people

Nishtala, P. S., Narayan, S. W., Wang, T., & Hilmer, S. N. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3624 · Cited by 126 · see citing works

Investigating polypharmacy and drug burden index in hospitalised older people

Best, G., Gnjidic, D., Hilmer, S. N., Naganathan, V., & McLachlan, A. J. (2013) · Internal Medicine Journal · doi:10.1111/imj.12203 · Cited by 116 · see citing works

Overview of Muscarinic Receptor Subtypes

Eglen, R. M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-23274-9_1 · Cited by 116 · see citing works

Anticholinergic Drug Burden in Older People's Brain - How well is it Measured?

Kersten, H., & Wyller, T. B. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12140 · Cited by 112 · see citing works

Medication and Falls: Risk and Optimization

Boyle, N., Naganathan, V., & Cumming, R. G. (2010) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2010.06.007 · Cited by 109 · see citing works

Trends in potentially inappropriate prescribing amongst older UK primary care patients

Wilde, S. D., Carey, I. M., Harris, T. J., Richards, N., Victor, C. R., Hilton, S. R., & Cook, D. G. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1306 · Cited by 106 · see citing works

Measures of Anticholinergic Drug Exposure, Serum Anticholinergic Activity, and All-cause Postdischarge Mortality in Older Hospitalized Patients with Hip Fractures

Mangoni, A. A., Munster, B. C. V., Woodman, R. J., & de Rooij, S. E. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.012 · Cited by 106 · see citing works

Muscarinic Receptors: Their Roles in Disorders of the Central Nervous System and Potential as Therapeutic Targets

Scarr, E. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00249.x · Cited by 105 · see citing works

Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patients

Cancelli, I., Beltrame, M., Gigli, G. L., & Valente, M. (2009) · Neurological Sciences · doi:10.1007/s10072-009-0033-y · Cited by 104 · see citing works

Impact of High Risk Drug Use on Hospitalization and Mortality in Older People with and without Alzheimer’s Disease: A National Population Cohort Study

Gnjidic, D., Hilmer, S. N., Hartikainen, S. A., Tolppanen, A., Taipale, H. T., Koponen, M., & Bell, J. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083224 · Cited by 104 · see citing works

Anticholinergic Drug Use, Serum Anticholinergic Activity, and Adverse Drug Events Among Older People: A Population-Based Study

Lampela, P., Lavikainen, P., Garcia-Horsman, A., et al. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0063-2 · Cited by 94 · see citing works

Drug Burden Index, Physical Function, and Adverse Outcomes in Older Hospitalized Patients

Lowry, E., Woodman, R. J., Soiza, R. L., Hilmer, S. N., & Mangoni, A. A. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011421489 · Cited by 88 · see citing works

Associations Between the Anticholinergic Risk Scale Score and Physical Function: Potential Implications for Adverse Outcomes in Older Hospitalized Patients

Lowry, E., Woodman, R. J., Soiza, R. L., & Mangoni, A. A. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.03.006 · Cited by 88 · see citing works

Serum anticholinergic activity and cerebral cholinergic dysfunction: An EEG study in frail elderly with and without delirium

Thomas, C., Hestermann, U., Kopitz, J., Plaschke, K., Oster, P., Drießen, M., Mundt, C., & Weisbrod, M. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-86 · Cited by 85 · see citing works

Anticholinergic Drug Use and Mortality Among Residents of Long-Term Care Facilities: A Prospective Cohort Study

Kumpula, E., Bell, J. S., Soini, H., & Pitkälä, K. H. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010368410 · Cited by 84 · see citing works

Snipping the thread of life. Antimuscarinic side effects of medications in the elderly

Peters, N. L. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.11.2414 · Cited by 83 · see citing works

Adverse Geriatric Outcomes Secondary to Polypharmacy in a Mouse Model: The Influence of Aging

Huizer‐Pajkos, A., Kane, A. E., Howlett, S. E., Mach, J., Mitchell, S. J., de Cabo, R., Couteur, D. G. L., & Hilmer, S. N. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv046 · Cited by 75 · see citing works

Central Anticholinergic Hypersensitivity in Aging

Ray, P. G., Meador, K. J., Loring, D. W., Zamrini, E. W., Yang, X., & Buccafusco, J. J. (1992) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/002383099200500203 · Cited by 74 · see citing works

Geriatric Drug Evaluation

Cho, S., Lau, S. W. J., Tandon, V., et al. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.152 · Cited by 72 · see citing works

Serum Anticholinergic Activity and Motor Performance in Elderly Persons

Nebes, R. D., Pollock, B. G., Halligan, E. M., Kirshner, M. A., & Houck, P. R. (2007) · The Journals of Gerontology Series A · doi:10.1093/gerona/62.1.83 · Cited by 72 · see citing works

Drugs With Anticholinergic Properties as a Risk Factor for Cognitive Impairment in Elderly People

Cancelli, I., Gigli, G. L., Piani, A., et al. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31818ce849 · Cited by 71 · see citing works

Basic and modern concepts on cholinergic receptor: A review

(2013) · doi:10.1016/s2222-1808(13)60094-8 · Cited by 71 · see citing works

Methodological Challenges in Determining Longitudinal Associations Between Anticholinergic Drug Use and Incident Cognitive Decline

Kashyap, M., Belleville, S., Mulsant, B. H., et al. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12632 · Cited by 71 · see citing works

Changes in anticholinergic load from regular prescribed medications in palliative care as death approaches

Agar, M. R., Currow, D. C., Plummer, J., Seidel, R., Carnahan, R. M., & Abernethy, A. P. (2009) · Palliative Medicine · doi:10.1177/0269216309102528 · Cited by 71 · see citing works

A Critical Appraisal of the Utility of the Serum Anticholinergic Activity Assay in Research and Clinical Practice

Carnahan, R. M., PharmD, Lund, B. C., PharmD, Perry, P. J., PhD, Pollock, A. B. G., MD, & PhD. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4221 · Cited by 67 · see citing works

The Withdrawal of Benztropine Mesylate in Chronic Schizophrenic Patients

Baker, L. A., Cheng, L. Y., & Amara, I. B. (1983) · The British Journal of Psychiatry · doi:10.1192/bjp.143.6.584 · Cited by 66 · see citing works

The relationship of serum anticholinergic activity to mental status performance in an elderly nursing home population

Tollefson, G. D., MONTAGUE-CLOUSE, J., & Lancaster, S. P. (1991) · Journal of Neuropsychiatry · doi:10.1176/jnp.3.3.314 · Cited by 65 · see citing works

The challenge of supporting care for dementia in primary care

Boustani, M. A. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s1802 · Cited by 63 · see citing works

Dealing with behavioral and psychological symptoms of dementia: a general overview

Azermai, M. (2015) · Psychology Research and Behavior Management · doi:10.2147/prbm.s44775 · Cited by 63 · see citing works

Effects of discontinuation of long-term biperiden use on cognitive function and quality of life in schizophrenia

Ogino, S., Miyamoto, S., Tenjin, T., Kitajima, R., Ojima, K., Miyake, N., Funamoto, Y., Arai, J., Tsukahara, S., Ito, Y., et al. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.030 · Cited by 59 · see citing works

Association of Anticholinergic Drugs with Hospitalization and Mortality among Older Cardiovascular Patients

Uusvaara, J., Pitkälä, K. H., Kautiainen, H., Tilvis, R. S., & Strandberg, T. E. (2010) · Drugs & Aging · doi:10.2165/11585060-000000000-00000 · Cited by 58 · see citing works

The use of medications with anticholinergic properties and risk factors for their use in hospitalised elderly patients

Wawruch, M., Mačugová, A., Kostkova, L., Luha, J., Dukát, A., Murín, J., Drobná, V., Wilton, L., & Kuželová, M. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2169 · Cited by 57 · see citing works

Association between prescribing of antimuscarinic drugs and antimuscarinic adverse effects in older people

Bostock, C. V., Soiza, R. L., & Mangoni, A. A. (2010) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.10.34 · Cited by 56 · see citing works

Zygomycosis in pregnancy

Wiwanitkit, S., & Wiwanitkit, V. (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.91219 · Cited by 55 · see citing works

G-protein–gated TRP-like Cationic Channel Activated by Muscarinic Receptors

Zholos, A. V., Zholos, A. A., & Bolton, T. B. (2004) · The Journal of General Physiology · doi:10.1085/jgp.200309002 · Cited by 55 · see citing works

Gentamicin pharmacokinetics in old age and frailty

Hilmer, S. N., Tran, K., Rubie, P., Wright, J., Gnjidic, D., Mitchell, S. J., Matthews, S. T., & Carroll, P. R. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03825.x · Cited by 54 · see citing works

Relationship of psychopathological symptoms and cognitive function to subjective quality of life in patients with chronic schizophrenia

Tomida, K., Takahashi, N., Saito, S., Maeno, N., Iwamoto, K., Yoshida, K., Kimura, H., Iidaka, T., & Ozaki, N. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.02033.x · Cited by 54 · see citing works

Sensitivity to Antipsychotic Drugs in Older Adults

Leon, C., Gerretsen, P., Uchida, H., Suzuki, T., Rajji, T. K., & Mamo, D. C. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-009-0080-3 · Cited by 47 · see citing works

Drug Burden Index and Hospitalization among Community-Dwelling Older People

Lönnroos, E., Gnjidic, D., Hilmer, S. N., Bell, J. S., Kautiainen, H., Sulkava, R. O., & Hartikainen, S. A. (2012) · Drugs & Aging · doi:10.2165/11631420-000000000-00000 · Cited by 47 · see citing works

Nortriptyline metabolism in chronic renal failure: Metabolite elimination

Dawling, S., Lynn, K. L., Rosser, R., et al. (1982) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1982.167 · Cited by 47 · see citing works

Pharmacokinetic and pharmacodynamic characterization of OROS® and immediate‐release amitriptyline

Gupta, S. K., Shah, J. C., & Hwang, S. S. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00973.x · Cited by 46 · see citing works

Significant correlation between plasma and CSF anticholinergic activity in presurgical patients

Plaschke, K., Thomas, C., Engelhardt, R., Teschendorf, P., Hestermann, U., Weigand, M. A., Martin, E., & Kopitz, J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.02.015 · Cited by 46 · see citing works

THE ROLE OF M2 MUSCARINIC RECEPTOR SUBTYPES IN MEDIATING CONTRACTION OF THE PIG BLADDER BASE AFTER CYCLIC ADENOSINE MONOPHOSPHATE ELEVATION AND/OR SELECTIVE M3 INACTIVATION

Yamanishi, T., Chapple, C. R., Yasuda, K., et al. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)65475-4 · Cited by 46 · see citing works

Effects of Potent Anticholinergics, Sedatives and Antipsychotics on Postoperative Mortality in Elderly Patients with Hip Fracture

Panula, J., Puustinen, J., Jaatinen, P. T., Vahlberg, T. J., Aarnio, P. T. T., & Kivelä, S. (2009) · Drugs & Aging · doi:10.2165/11317660-000000000-00000 · Cited by 41 · see citing works

Impact of Anticholinergic Discontinuation on Cognitive Outcomes in Older People: A Systematic Review

Salahudeen, M. S., Duffull, S. B., & Nishtala, P. S. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0158-4 · Cited by 41 · see citing works

Drug Access to the Central Nervous System in Alzheimer’s Disease: Preclinical and Clinical Insights

Mehta, D. C., Short, J., Hilmer, S., & Nicolazzo, J. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1522-0 · Cited by 41 · see citing works

Anticholinergic Activity of Commonly Prescribed Medications and Neuropsychiatric Adverse Events in Older People

Nishtala, P. S., Fois, R. A., McLachlan, A. J., Bell, J. S., Kelly, P. J., & Chen, T. F. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009345690 · Cited by 40 · see citing works

Merck Manual : for health care professionals

Porter, R. S., & Kaplan, J. L. (2011) · Cited by 38 · see citing works

ON THE MUSCARINIC RECEPTORS IN THE URINARY BLADDER AND THE PUTATIVE SUBCLASSIFICATION OF MUSCARINIC RECEPTORS

Nilvebrant, L. (1986) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1986.tb03647.x · Cited by 37 · see citing works

Development, validation and evaluation of an electronic pharmacological tool: The Drug Burden Index Calculator©

O’Donnell, L. K., Gnjidic, D., Chen, T. F., & Hilmer, S. N. (2015) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2015.11.002 · Cited by 37 · see citing works

Effects of Anticholinergic Drug Withdrawal on Memory, Regional Cerebral Blood Flow and Extrapyramidal Side Effects in Schizophrenic Patients

Mori, K., Yamashita, H., Nagao, M., Horiguchi, J., & Yamawaki, S. (2002) · Pharmacopsychiatry · doi:10.1055/s-2002-19831 · Cited by 36 · see citing works

Serum Anticholinergic Activity: A Possible Peripheral Marker of the Anticholinergic Burden in the Central Nervous System in Alzheimer’s Disease

Hori, K., Konishi, K., Tani, M., et al. (2014) · Disease Markers · doi:10.1155/2014/459013 · Cited by 35 · see citing works

Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease

Tsang, S. W. Y., Pomakian, J., Marshall, G. A., Vinters, H. V., Cummings, J. L., Chen, C., Wong, P. T. ‐., & Lai, M. K. P. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.001 · Cited by 35 · see citing works

Anticholinergic Component of the Drug Burden Index and the Anticholinergic Drug Scale as Measures of Anticholinergic Exposure in Older People in New Zealand: A Population-Level Study

Narayan, S. W., Hilmer, S. N., Horsburgh, S., & Nishtala, P. S. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0111-y · Cited by 35 · see citing works

Determinants of antipsychotic medication use among older people living in aged care homes in Australia

Nishtala, P. S., McLachlan, A. J., Bell, J. S., & Chen, T. F. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2359 · Cited by 35 · see citing works

Paying Attention to Pharmacokinetic and Pharmacodynamic Mechanisms to Progress in the Area of Anticholinergic Use in Geriatric Patients

de León, J. (2011) · Current Drug Metabolism · doi:10.2174/138920011796504518 · Cited by 34 · see citing works

The relationship between total anticholinergic burden (ACB) and early in-patient hospital mortality and length of stay in the oldest old aged 90 years and over admitted with an acute illness

Kidd, A. C., Musonda, P., Soiza, R. L., et al. (2014) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2014.01.006 · Cited by 32 · see citing works

Anticholinergic Drugs and Functional Outcomes in Older Patients Undergoing Orthopaedic Rehabilitation

Koshoedo, S. A., Soiza, R. L., Purkayastha, R., et al. (2012) · ˜The œAmerican journal of geriatric pharmacotherapy · doi:10.1016/j.amjopharm.2012.06.003 · Cited by 31 · see citing works

Anticholinergics and central nervous system effects: are we confused?

Staskin, D. R., & Zoltan, E. (2007) · Europe PMC (PubMed Central) · Cited by 29 · see citing works

Risk for Fractures with Centrally Acting Muscle Relaxants: An Analysis of a National Medicare Advantage Claims Database

Golden, A. G., Ma, Q., Nair, V. P., Florez, H. J., & Roos, B. A. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1p210 · Cited by 28 · see citing works

Anticholinergic burden in older women: not seeing the wood for the trees?

Parkinson, L., Magin, P. J., Thomson, A., et al. (2015) · The Medical Journal of Australia · doi:10.5694/mja14.00336 · Cited by 25 · see citing works

The Influence of Patient Characteristics on Anticholinergic Events in Older People

Salahudeen, M. S., Nishtala, P. S., & Duffull, S. B. (2016) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000441718 · Cited by 23 · see citing works

Hypothesis of Endogenous Anticholinergic Activity in Alzheimer's Disease

Konishi, K., Hori, K., Tani, M., et al. (2015) · Neurodegenerative Diseases · doi:10.1159/000381511 · Cited by 19 · see citing works

The effects of abrupt antipsychotic discontinuation in cognitively impaired older persons: A pilot study

Azermai, M., Petrović, M., Engelborghs, S., Elseviers, M. M., der Mussele, S. V., Debruyne, H., Bortel, L. M. V., & Stichele, R. V. (2012) · Aging & Mental Health · doi:10.1080/13607863.2012.717255 · Cited by 19 · see citing works

Behavioral and psychological symptoms of dementia (BPSD) in elderly demented subjects: Is the long lasting use of atypical antipsychotic drugs useful and safe?

Angelini, A., Bendini, C., Neviani, F., & Neri, M. (2007) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2007.01.005 · Cited by 18 · see citing works

Drugs with anticholinergic properties: a potential risk factor for psychosis onset in Alzheimer's disease?

Cancelli, I., Beltrame, M., D’Anna, L., Gigli, G. L., & Valente, M. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903099636 · Cited by 18 · see citing works

Flaws in the Serum Anticholinergic Activity Assay: Implications for the Study of Delirium

Cox, E. A., Kwatra, S. G., Shetty, S., & Kwatra, M. M. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02411.x · Cited by 17 · see citing works

Heat stroke associated with medications having anticholinergic effects.

Adams, B. E., Manoguerra, A. S., Lilja, G. P., Long, R. S., & Ruiz, E. (1977) · PubMed · Cited by 17 · see citing works

Altered Amitriptyline Kinetics in a Depressed Patient with Porto-Caval Anastomosis

Hrdina, P. D., Lapierre, Y. D., & Koranyi, E. K. (1985) · The Canadian Journal of Psychiatry · doi:10.1177/070674378503000205 · Cited by 14 · see citing works

[Proposal of endogenous anticholinergic hypothesis in Alzheimer disease].

Hori, K., Konishi, K., Akita, R., et al. (2013) · PubMed · Cited by 12 · see citing works

Oral Solid Potassium Chloride and Anticholinergic Medications: A New Drug Interaction for an Old Drug?

Zarowitz, B. J. M. (2006) · Geriatric Nursing · doi:10.1016/j.gerinurse.2006.10.015 · Cited by 11 · see citing works

A Pilot Project to Assess the Association of Anticholinergic Symptoms With Anticholinergic Serum Levels in the Elderly

Rémillard, A. J. (1994) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1994.tb02840.x · Cited by 10 · see citing works

Amitriptyline Metabolism in Elderly Depressed Patients and Normal Controls in Relation to Hypothalamic-Pituitary-Adrenal System Function

Schmider, J., Deuschle, M., Schweiger, U., Kørner, A., Gotthardt, U., & Heuser, I. J. E. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199508000-00003 · Cited by 7 · see citing works

Cholinergic transmission

Rang, H., Dale, M., Ritter, J., et al. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-06911-6.50015-3 · Cited by 6 · see citing works

Pharmacotherapy for Neurocognitive Disorders Based on the Hypothesis of Endogenous Appearance of Anticholinergic Activity

Hosoi, M., Hori, K., Konishi, K., et al. (2015) · Neurodegenerative Diseases · doi:10.1159/000381513 · Cited by 4 · see citing works

Serum anticholinergic activity in patients following cardiac surgery and healthy individuals following amitriptyline application

Brecht, S., Reiff, J., Vock, U., et al. (2007) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2007.29.3.1075357 · Cited by 4 · see citing works

Anticholinergic Activity and Alzheimer's Disease

Hori, K., Hachisu, M., Tomioka, H., et al. (2015) · Neurodegenerative Diseases · doi:10.1159/000381482 · Cited by 4 · see citing works

CAMDEX, can it be more efficient? observational study on the contribution of four screening measures to the diagnosis of dementia by a memory clinic team

(2001) · Pure Amsterdam UMC · doi:10.1002/1099-1166(200101)16:1 · Cited by 3 · see citing works

PMH21 PREVALENCE AND PREDICTORS OF ANTICHOLINERGIC MEDICATION USE IN ELDERLY NURSING HOME RESIDENTS WITH DEMENTIA

Chatterjee, S. S., Palli, S., Mehta, S., et al. (2010) · Value in Health · doi:10.1016/s1098-3015(10)72517-1 · Cited by 1 · see citing works

The Impact of Anticholinergic Burden on Functional Capacity in Persons With Schizophrenia Across the Adult Life Span

Khan, W. U., Ghazala, Z., Brooks, H. J., Subramaniam, P., Mulsant, B. H., Kumar, S., Voineskos, A. N., Blumberger, D. M., Kern, R. S., & Rajji, T. K. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa093 · Cited by 27 · see citing works

Deprescribing anticholinergic medications may be key to optimal outcomes in older adults

Chan, C. (2022) · Pharmacy Today · doi:10.1016/j.ptdy.2022.10.011 · Cited by 1 · see citing works

Pharmacology of zolimidine (2-(p-methylsulfonylphenyl)-imidazo (1,2-a) pyridine) a new non-anticholinergic gastroprotective agent. IV) Enhancement of gastric mucus production in different experimental models.

Murmann, W., Gm, C., & Cattaneo, R. (1974) · PubMed · Cited by 1 · see citing works

Acute Asthma in Children and Adolescents

Plotnick, L. H., & Ducharme, F. M. (2003) · American Journal of Respiratory Medicine · doi:10.1007/bf03256642 · Cited by 38 · see citing works

[Synthesis and anticholinergic activity of some derivatives of substituted glycolates].

Bl, G., Rq, W., Qm, T., et al. (1985) · PubMed

Combined Inhaled Short-Acting Beta2 Agonist and Anticholinergic Agents for Asthma.

Runde, D. P., & Rallo, M. (2018) · PubMed · Cited by 1 · see citing works